Letters
Safety of tamoxifen
BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6927.534 (Published 19 February 1994) Cite this as: BMJ 1994;308:534
- G M Williams
- American Health Foundation, Valhalla, NY 10595, USA.
EDITOR, - V Craig Jordan reports some of the preclinical toxicological findings on tamoxifen in his editorial.1 Though he states that tamoxifen “promotes hepatic tumours in rats,” he fails to note that tamoxifen is a strong liver carcinogen by itself in rats, producing tumours within six months and a high incidence by one year at doses that yield …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.